app_store_button

google_play_button

PL - Details page - Device banner - 894x1036

Witaj w nieskończonym świecie literatury

Storytel Unlimited 50% taniej przez 4 miesiące

BBC World Service

Discovery

What if robots of the future weren’t just clever machines, performing tasks in isolation, but trusted teammates you could have a chat with? That could respond naturally to conversational cues and even explain their work? Making this relationship a reality is a focus for Helen Hastie, Professor of Human-Robot Interaction and Head of the School of Informatics at the University of Edinburgh. Helen’s career has taken her from developing early dialogue systems - the ancestors of today’s generative AI - to working on sophisticated bots that can serve coffee with a side of small-talk, teach struggling kids with empathy, or provide calm and confident decisions as triage nurses. She’s also driven some of the UK’s flagship robotics initiatives, including as co-lead of the National Robotarium. Talking to Professor Jim Al-Khalili - who reveals he was once told off for rudeness by an early chatbot - Helen explains her hopes for useful, reliable and ultimately trustworthy robots; machines that aren’t just in our world but a welcome part of it.

The Life Scientific: Helen Hastie

Dr Seth Berkley is an epidemiologist and global health leader whose career has been shaped by one central problem: vaccines save lives, but only if people can actually get them. His 40-year career has spanned the global, from helping to build Uganda’s first HIV surveillance system and founding the International AIDS Vaccine Initiative; to leading Gavi, the Vaccine Alliance for more than a decade – overseeing the immunisation of hundreds of millions of children worldwide. And when COVID-19 struck, Seth co-founded COVAX, the global initiative designed to stop wealthy nations monopolising vaccines. In conversation with Professor Jim Al-Khalili, Seth discusses the highs and lows of his globe-trotting career - from saving millions of young lives through vaccine distribution, to setting his own shattered leg after a climbing accident in Namibia - and addresses the huge challenge of tackling vaccine scepticism.

The Life Scientific: Seth Berkley

Hiranya Peiris is playing a starring role in a movie that promises to tell perhaps the greatest story of all time. However, it’s a movie with a difference – there’s no director and no script. The Legacy Survey of Space and Time is one of the most ambitious projects in the world of astronomy, with a mission to create a decade-long time-lapse movie of the visible universe, to answer fundamental questions about its origin, evolution and, ultimately, its fate.

Hiranya is Professor of Astrophysics 1909, the prestigious Chair at the Institute of Astronomy at Cambridge University. Over her career she’s been one of the pioneers of a revolution in astronomy, bridging fundamental physics with the observational data coming back from space, to establish the first evidence-based standard model for the origin, evolution and fate of the universe. The endeavour has transformed the field from the ‘wild west’ of physics to the modern era of precision cosmology.

Ironically, it was another movie, of sorts, Carl Sagan’s documentary series ‘Cosmos’, that first sparked Hiranya’s interest in the universe as a young girl. Always keen to inspire women to follow in her footsteps and choose careers in science, if this interview were a live show she’d have reserved the front row for schoolgirls.

The Life Scientific: Hiranya Peiris

As a child growing up on the shores of Lake Victoria in western Kenya, Washington Yotto Ochieng once watched a plane cross the night sky and told his mother he wished he could travel on it. But he remembers her encouraging him to dream bigger... Today, Washington is a Professor of Engineering at Imperial College London, and President of the Royal Institute of Navigation. Over a career bridging industry and academia, he has helped shape the movement of urban transport; how satellites guide us and locate us; and how governments manage the technologies underpinning so much of modern life. Professor Jim Al-Khalili speaks to Washington about his inspirational upbringing, how reliant we've become on technologies such as GPS, and his work encouraging the next generation of engineers in both the UK and Africa.

The Life Scientific: Washington Yotto Ochieng

Working on a remote tropical island in the Atlantic might sound like some sort of romantic idyll - but trying to conduct scientific research on a windy, isolated volanic outcrop is no picnic, as Lucy Carpenter can attest! Lucy is an atmopsheric chemist and a Professor at the University of York, whose work has helped to transform understanding of how oceans shape the air above them. She was one of the founding scientists behind the Cape Verde Atmospheric Observatory, established on São Vicente in 2006 and now a key global monitoring site. Measurements made there helped overturn a long-standing assumption: ozone loss is not solely a human-made problem. Lucy and her colleagues showed that gases released by natural marine processes can trigger chemical reactions that destroy ozone - demonstrating that the sea is not simply a passive backdrop to climate change but an active participant; affecting aerosols, clouds and ultimately the climate itself. More recently Lucy's expertise has taken her into the policy arena, co-chairing the scientific assessment panel for the Montreal Protocol: the international agreement designed to protect the ozone layer. In conversation with Professor Jim Al-Khalili, Lucy discusses her journey from sampling ocean air to turning the tide of global environmental policy - and explains why her passion for duathlons could arguably be seen as an easier pastime than scientific research.

The Life Scientific: Lucy Carpenter

As recently as a few years ago, the idea of a self-administered injection that would deliver proven weight-loss results might have sounded fantastical. Today, these medications are a reality and a global phenomenon; hailed in many quarters as “miracle drugs" for their success in treating obesity and diabetes. They do this by replicating a gut hormone called GLP‑1, which tells the brain you’ve eaten enough and nudges the pancreas to release insulin; and this hormone was discovered and decoded thanks to years of work by today's guest. Jens Juul Holst is a Professor of Medical Physiology and Biomedical Sciences at the University of Copenhagen. His efforts laid the groundwork for today’s weight loss jabs, earning him a slew of high-profile accolades and awards. Now it seems they might not only have positive impacts on obesity and diabetes, but also other health issues... But alongside the big success comes some big questions: including concerns over side effects, weight regain post-treatment, the black market in such drugs, and their cost and accessibility. In a frank conversation with Professor Jim Al-Khalili, Jens address these issues and shares his hopes for the future of GLP-1-focused research.

The Life Scientific: Jens Juul Holst

It's a rare thing to encounter a medical specialist who has experience of his field from the expert and the patient perspective - but not unheard of...

Jim Ashworth-Beaumont is an orthotist and prosthetist who spent years helping people adapt to life with artificial limbs and musculoskeletal supports, before a near-fatal accident left him relying on both.

This twist of fate might have derailed many - but Jim drew on reserves of resilience and determination forged long before his accident; initially in the army, then by returning to education to earn the qualifications he missed out on as a youngster. He put himself through night school before earning a place to study Prosthetics and Orthotics at the University of Strathclyde. Later, while working at London’s Royal National Orthopaedic Hospital, Jim completed a Master’s in Neurorehabilitation, and a PhD in Health Studies – driven by a fascination with how the human body adapts under pressure.

But in 2020, while training for a triathlon, Jim was involved in a catastrophic cycling accident that nearly killed him - and cost him an arm.
He tells Jim Al-Khalili how the incident gave him a whole new insight into his patients’ experience and made him more determined than ever to achieve his goals.

Presented by Jim Al-Khalili
Produced by Lucy Taylor

The Life Scientific: Jim Ashworth-Beaumont

“I shall largely speak of mice,” the paper begins “but my thoughts are on man.”

So begins a truly extraordinary scientific paper, and an equally extraordinary story.

“Death Squared: The Explosive Growth and Demise of a Mouse Population.” was published in 1973 by John Calhoun, and it detailed his increasingly bizarre research into the psychological effects of overcrowding. Over two decades he built a series of ‘rodent utopias’, where he could keep a population of rats or mice, meet all their basic food and shelter needs, but mess around with population levels. He wanted to see how they responded to having to live, cheek-by-tiny-jowl, with far more other rats than they were used to. And it wasn’t pretty. Social orders melted into chaos, rodents fought indiscriminately, or shut themselves away at the top of the enclosure. Mating orders collapsed, population numbers tanked, and eventually, every single rat was dead.

His work came at a prescient time. In the 60s and 70s, the exponentially expanding human population was a hot-button topic, and ‘population panic’ was in full swing. Alongside the expansion of cities, creeping urban sprawl, rising city-centre crime rates and 'urban sinks', there grew a concern that human living conditions were about to take an interminable dive. How would we live, with so many of us on earth? Calhoun’s work was leapt on by the press and public as a dire prediction of our own coming collapse. His rodent utopias became a subject of great interest among architects and city planners, psychologists and sociologists, and anyone fascinated by the human condition. But has his work been misunderstood?

50 years on, what lessons can we take from the work of a ground-breaking but often misunderstood scientist, in the face of a human population now exceeding 8 billion. Emily Knight explores his extraordinary work, its implications for humanity, and the possibility of a human utopia, that might not look anything like you expect.

Presented and Produced by Emily Knight in Cardiff

Inside Universe 25

In July 2024 a startling scientific paper was published.

Headlined ‘Evidence of dark oxygen production at the abyssal seafloor’, scientists told how they had discovered oxygen being made two and a half miles down, at the bottom of the Pacific Ocean.

Their claim centred on small polymetallic nodules on the seafloor, and the key question - could these lumps of metal somehow be making oxygen in complete darkness?

It was an extraordinary finding that, if proven, could overturn hundreds of years of scientific knowledge about how this crucial ingredient for life is made. It prompted global headlines and split scientists.

But a year and a half on, are we any closer to knowing the answer... Is dark oxygen really possible?

BBC News science correspondent Victoria Gill investigates for BBC Radio 4, and finds so much more than a scientific anomaly.

Dark Breath is the story of a scientific controversy played out in real time. A row about science that became personal. And a discovery that crashed headlong into the debate about whether we should mine metals from the deep sea.

What does the story tell us about the messy and human scientific process? And what bearing does it have on the decision to exploit some of the last untouched parts of our planet?

Presenter: Victoria Gill
Producer: Gerry Holt
Editor: Ilan Goodman

Dark Breath

The rapid spread of antibiotic resistant bacteria is already claiming lives - and a far greater global crisis is on the horizon.

In this three part series for Discovery, reporter Roland Pease traces how we reached this point, uncovers the forces driving resistance ever faster, and meets the scientists racing to outpace evolving superbugs before our lifesaving medicines fail for good.

Episode 3 - Failed market. A successful new antibiotic must not only treat bacteria that resist existing therapies, it must be kept in reserve for only the hardest cases lest new kinds of resistance evolve, and yet it must pay back the developers' investment. No wonder several leading antibiotic companies have failed financially in the past 8 years. Is there a way to make antibiotic development pay?

Superbugs: Resistance Rising Part 3

As the pace of technology moves at ever greater speeds, how vulnerable are we when making split second decisions? Kevin Fong flies with the Helicopter Emergency Medical Service, making split-second, life-or-death decisions. He examines how we can come to terms with the growing challenge of quick and accurate front line decision making.

Picture: Presenter, Kevin Fong in air ambulance, Credit: BBC

The Split Second Decision

Storytel Unlimited 50% taniej przez 4 miesiące

Możesz polubić także ...